The global Hematology market size is expected to reach USD 10.20 Billion in 2030 and register a revenue CAGR of 4.93% during the forecast period, according to latest report by Reports and Data. Demand for hematological diagnostics is expected to increase, owing to rising awareness about blood disorders among healthcare providers and patients, which is expected to drive market revenue growth over the forecast period.

Hematology diagnostic procedures are widely used to diagnose blood-related disorders such as anemia, blood cancer such as leukemia, and bleeding disorders such as blood clotting disorders and hemophilia. Apart from disease detection, Hematology aid in proper blood count and characterization of blood cells. The widely used hematology diagnostic systems include hemostasis, immunohematology, hematology reagents, and hematology rapid tests.

Hematology refers to the study of blood, blood-related diseases, and blood components, and Hematology include a wide array of advanced hematology tests performed using whole blood, urine, serum, cerebrospinal fluid, and other bodily fluids. These tests involve use of different In Vitro Diagnostic (IVD) technologies, such as flow cytometry, blood analysis, immunodiagnostics, hemostasis, and molecular diagnostics, to diagnose problems pertaining to blood and its components, including red blood cells, white blood cells, lymph, plasma, and platelets.

Use of Hematology has increased in recent times, owing to increasing incidence of blood disorders. Factors such as an aging population, technological developments, and increasing need for better healthcare facilities are likely to boost the global Hematology market. The global market is also being driven by increasing government initiatives across the world to boost healthcare infrastructure. However, high costs of diagnostics and lack of coverage for diagnostic procedures in health insurance plans in many countries are two major challenges limiting revenue growth of the global Hematology market. Moreover, lack of public awareness about Hematology is also expected to restrict market revenue growth to some extent.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/4057

Some Key Highlights from the Report:

Based on product type, the consumables segment is expected to account for largest revenue share and register the fastest growth rate during the forecast period, due to low manufacturing costs, increasing availability of consumables for certain analyzer tests, and increase in the number of tests needed by consumers. In hematology analyzers, consumables are utilized to lyse red blood cells from blood samples prior to leukocyte examination. Direct dependency of hematology tests on consumables is one of the main factors to drive revenue growth of the segment during the forecast period. Rising awareness about blood disorders among healthcare professionals and patients is also expected to increase demand for hematology analyzers and in turn, demand for consumables.

Based on test type, the full blood count testing segment is expected to register a significantly faster growth rate over the forecast period. Full blood count tests are useful for general evaluation of health during routine check-ups, and they evaluates three major components found in the blood – white blood cells, red blood cells, and platelets. Several conditions, such as anemia, allergy, vitamin and iron deficiencies, and infections, can be easily diagnosed with the help of these tests.

Based on end user, the hospitals & clinics segment is expected to register the fastest revenue CAGR over the forecast period. Hospitals & clinics segment is expected to lead in terms of revenue share over the forecast period, due to increase in demand for Hematology among individuals who require routine blood testing, such as diabetics and cancer patients. Moreover, This segment is expected to register a rapid growth rate, which can be attributed to a larger patient influx in hospitals as compared to other healthcare facilities and increasing number of registered hospitals across the globe.

The Asia-Pacific market is expected to register the fastest revenue growth rate in the global market during the forecast period. Rapid urbanization, increasing incidence of chronic diseases, such as cancer and hematological diseases, particularly in developing countries including India and China, and improving healthcare infrastructure are some major factors driving revenue growth of the market in Asia-Pacific.

According to the National Institute of Cancer Prevention and Research (NICPR), over 1.1 million cancer cases are recorded in India each year. Thus, high prevalence of cancer in various countries in the region is expected to increase demand for Hematology in Asia-Pacific.

Statistical Analysis:

The information is for the most part accumulated in different courses of action like diagrams, charts, infographics, patterns, reports, and records from different makers and retailers. Our subject specialists accumulate, gather, and decipher such information to frame huge data sets. Our group then, at that point, works with huge information volumes to break down center turns of events, assess market assessments, and distinguish patterns.

We give measurable demonstrating, inferential factual investigation, unmistakable factual examination, and prescient investigation among different kinds of investigations. Subsequently, we furnish redid reports with information planning, the board, and investigation. We likewise have a consistent criticism framework, wherein our group guarantees that new market improvements are precisely consolidated in the past data sets.

Competitive Outlook of the Global Hematology Market

The globla Hematology market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Hematology market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers & acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.

Top Companies Profiled in the Report:

Abbott Laboratories, Beckman Coulter, Inc., Ortho Clinical Diagnostics, Siemens Healthineers, Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Mindray Medical International Limited, Drew Scientific Inc., Bio-Rad Laboratories Inc., HemoCue AB, Horiba Ltd., EKF Diagnostics, and Nihon Kohden Corporation, among others.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/4057

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

Hematology Market Segmentation:

Product Type Outlook (Revenue, USD Billion; 2019-2030)

Instruments
Consumables

Test Type Outlook (Revenue, USD Billion; 2019-2030)

Full Blood Count Testing
Hemoglobin Testing
Blood Glucose Testing
Renal Profiling
Vitamin B12 Deficiency Testing
Others

End-Use Outlook (Revenue, USD Billion; 2019-2030)

Hospitals and Clinics
Diagnostic Centers
Research Laboratories
Others

Geographic Segment Covered in the Report:

The Hematology report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

North America (USA and Canada)

Europe (UK, Germany, France and the rest of Europe)

Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)

Latin America (Brazil, Mexico, and the rest of Latin America)

Middle East and Africa (GCC and rest of the Middle East and Africa)

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4057

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Wolman Disease Treatment Market @ https://www.biospace.com/article/wolman-disease-treatment-market-future-challenges-and-industry-growth-outlook-2030-reports-and-data/

Hepatitis C Virus Treatment Market @ https://www.biospace.com/article/hepatitis-c-virus-treatment-market-analysis-size-share-growth-segment-trends-and-forecast-to-2030-reports-and-data/

Graves Ophthalmopathy Market @ https://www.biospace.com/article/graves-ophthalmopathy-market-research-on-demand-growth-trends-and-forecast-2030-reports-and-data/

Dupuytren’s Disease Treatment Market @ https://www.biospace.com/article/dupuytren-s-disease-treatment-market-to-witness-robust-expansion-throughout-the-forecast-by-2030-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com